Effects of Extra-Fine Inhaled and Oral Corticosteroids on Alveolar Nitric Oxide in COPD

Authors:

Abstract
Alveolar nitric oxide (CANO) has been suggested as a surrogate marker of distal airway inflammation in COPD. Coarse particle-inhaled corticosteroids (ICS) have been shown not to suppress CANO. We evaluated whether extra-fine particle size ICS (HFA-BDP) or systemic oral corticosteroids could suppress CANO in COPD. Chronic obstructive pulmonary disease (COPD) patients with a FEV1/FVC ratio NO was corrected for axial diffusion. In 16 participants, there were no significant differences seen with either dose of HFA-BDP compared with placebo. Oral prednisolone significantly reduced FENO and J’awNO but not CANO. Plasma cortisol was significantly suppressed by oral prednisolone only. Whilst CANO remains a biomarker of interest in COPD, it is not suppressed by systemic or extra-fine particle ICS. CANO is not a useful marker for monitoring response of small airway disease to therapies in COPD. The study was approved by the local Committee on Medical Research Ethics and registered on ClinicalTrials.Gov (NCT 00921921).

This publication has 26 references indexed in Scilit: